Patent · US Active

Analogs of glucagon exhibiting GIP receptor activity

US9868772B2 · kind B2 · utility

3Cited by

5References

3Claims

0Family size

Assignee

INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION · US

Inventors

Richard D. DiMarchi · Carmel, US
David L. Smiley · Greenfield, US
Konrad Bleicher · Glückstadt, DE
Eric A. Kitas · Aesch, CH

Key dates

Filing date	Jun 18, 2013
Grant date	Jan 16, 2018
Priority date	—
Expiry date	Oct 8, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are glucagon analogs which exhibit potent activity at the GIP receptor, and, as such are contemplated for use in treating diabetes and obesity. In exemplary embodiments, the glucagon analog of the present disclosures exhibit an EC50 at the GIP receptor which is within the nanomolar or picomolar range.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.